Navigation Links
Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC
Date:9/19/2007

ty against several clones of MRSA (E-MRSA, VISA, VRSA) predominant in community and hospital infections. Iclaprims Post Antibiotic Effect (PAE) was comparable to other agents in this study.

B-817: A novel staphylococcal murine preclinical model of infection was established for diaminopyrimidines. The efficacy of iclaprim was shown to be equal or better than that of vancomycin.

E-903, E-907, E-908, E-909: Iclaprim shows good activity against important pathogens such as Chlamydia trachomatis, Legionella pneumophila, Neisseria gonorrhoeae and Enterobacteriaceae. These are involved in various clinical indications.

A-804, A-805, A-806: Important Phase I data on intravenous and oral iclaprim. Iclaprim exhibited extensive tissue distribution, showed good oral bioavailability and was well-tolerated in volunteers.

A-803, A-807: these posters described important data on pharmacokinetics in the marmoset and in vitro interaction studies with CYP450 enzymes.

D-243, D-244, D-245: These posters describe the reliability of results when testing susceptibility for iclaprim using various methods and under different circumstances. The studies show a narrow range of test results and a good correlation between Minimum Inhibitory Concentrations (MICs) under different methods.

About Arpida Ltd.

Arpida (SWX: ARPN) is a biopharmaceutical company with research facilities near Basel, Switzerland and in the USA. It focuses on the discovery and development of novel drugs that seek to overcome the growing problem of microbial resistance.

Arpida's leading product candidate is intravenous iclaprim, a broad-spectrum antibiotic that targets severe infections requiring hospital treatment, including those caused by methicillin-resistant Staphylococcus aureus (MRSA). The US Food and Drug Administration has granted fast track status to intravenous iclaprim. In July 2007, Arpida reported the completion of the Phase III programme in complicated skin and skin
'/>"/>

SOURCE Arpida Ltd
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. NimbleGen presents new tech for comparing microbe DNA
2. Wisconsin Technology Network presents symposium on saving lives by the use of Information Technology
3. Thieme Presents Unique Technology Angle at Gov.s Conference
4. BioRobot MDx standardize your automated protocols in clinical laboratories
5. What patients want: A story of choice, clinical trials & evidence-based medicine
6. ZyStor seeks to raise $15M for clinical trials
7. Prodesse begins clinical trials for flu virus detection
8. ConjuGon raises $3.3 million to fund clinical trials
9. Cancer-fighting agent heads for clinical trials
10. Quintessence cancer treatment chosen for clinical studies
11. Third Wave reports clinical growth, continued loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... (PRWEB) January 15, 2014 More than ... and about 1 in 3 seniors will die with ... ). These jaw-dropping figures have shocked many Americans into ... hopefully, help prevent these tragic age-related cognitive disorders. Jonathan ...
(Date:1/15/2014)... Sunnyvale, CA (PRWEB) January 15, 2014 ... throughput research solutions, today announced that Lupin Limited, one ... of Freeslate’s CM Protégé PharmD System for ... in Mumbai, India, is focused on a wide range ...
(Date:1/14/2014)... Histogen, Inc., a regenerative medicine company developing ... simulated embryonic conditions, today announced that they have entered ... for physician-dispensed aesthetic products containing Histogen’s proprietary multipotent cell ... an amendment to the existing license between Histogen and ...
(Date:1/14/2014)... BETHESDA, Md. , Jan. 14, 2014  Organovo ... institutes from the National Institutes of Health (NIH) to ... more effective treatments to patients on a faster timeline. ... Translational Sciences (NCATS) and the National Eye Institute (NEI) ...
Breaking Biology Technology:Biohack Pure Offers 5 Tips for Increasing Memory in 2014 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 2Histogen and Suneva Medical Expand License for Cell Conditioned Media-based Aesthetic Products Internationally 3Organovo Announces Collaboration with National Institutes of Health 2Organovo Announces Collaboration with National Institutes of Health 3
... 26 Bionovo, Inc.,(Nasdaq: BNVI ) (the "Company") today ... of common stock at a price to the public of,$2.50 ... stock,at $3.50 per share at a price of $0.10 per ... to purchase up to an additional 15% of,the offering to ...
... - International Call for Patient Group Task ... international research, including the views of bodies that,represent ... today in,Dublin, Ireland - one of the world,s ... campaigner has called for patient,groups across Europe to ...
... Sunesis,Pharmaceuticals, Inc. (Nasdaq: SNSS ), a ... that,management will hold an investor conference call on ... PT to discuss financial results for the,third quarter ... the call via (888),297-0358 (U.S. and Canada) or ...
Cached Biology Technology:Bionovo Announces the Pricing of Public Offering of Shares of Common Stock 2Bionovo Announces the Pricing of Public Offering of Shares of Common Stock 3Patients Fail to Take Fake Medicines Risk Seriously 2Patients Fail to Take Fake Medicines Risk Seriously 3
(Date:4/17/2014)... new early-warning signs of the potential loss of sight ... for the diagnosis and treatment of diabetic retinopathy, potentially ... "We had not expected to see such striking changes ... Elsner, professor and associate dean in the IU School ... set out to study the early signs, in volunteer ...
(Date:4/17/2014)... wild animals and plant life, but there,s an invisible ... in the soil, decomposing organic matter and releasing carbon ... fungi play in ecological systems, their identities have only ... generated a genetic map of more than 10,000 species ... this week in the Proceedings of the National ...
(Date:4/17/2014)... View of Domestication," a special feature of The ... ( PNAS ) published April 29, raises a ... deep history that most of us take for granted. ... in many spots around the globe shifted from hunting ... and plants. , It seems so straightforward and yet ...
Breaking Biology News(10 mins):New technique detects microscopic diabetes-related eye damage 2New technique detects microscopic diabetes-related eye damage 3Stanford biologists help solve fungal mysteries 2Stanford biologists help solve fungal mysteries 3Genetic study tackles mystery of slow plant domestications 2Genetic study tackles mystery of slow plant domestications 3Genetic study tackles mystery of slow plant domestications 4
... August 8th, 2011, Shenzhen, China BGI, the ... Shenzhen Second People,s Hospital, announced today that the study ... cell carcinoma (TCC) of the bladder was published online ... valuable genetic basis for future studies on TCC, suggesting ...
... WEST LAFAYETTE, Ind. -- A Purdue University scientist is urging ... allowed for U.S. consumption and arguing that not doing so ... William Muir, a professor of animal sciences, said that based ... Administration, AquAdvantage (AA) salmon poses little real risk to the ...
... is currently used as a component of intravenous nutrition and ... protection for patients suffering from heart attacks. Current ... of the ischemic period, when blood flow to tissues is ... blood flow. It is well known that injury to the ...
Cached Biology News:Research discovers frequent mutations of chromatin remodeling genes in TCC of the bladder 2Scientist urges government ruling on genetically engineered salmon 2Scientist urges government ruling on genetically engineered salmon 3
... Technology's family of light scattering instruments. The ... chromatograph and enables you to get multi-angle ... HTmD is easily installed in the oven ... 2000 device and enables you to get ...
...
... Experion HighSens reagents and supplies, for ... supplies sufficient to perform high-sensitivity RNA ... on the Experion automated electrophoresis system. ... 20 microliters RNA HighSens stain, 20 ...
MAb to Verotoxin II (SLT-2a) Verotoxin II (Shiga-like) A subunit (SLT-2a)...
Biology Products: